India, June 3 -- Wednesday, Minimed Group, Inc (MMED), a medical technology company, reported a wider loss for the fourth quarter of 2026, ending April 24, despite higher revenue.
Net loss attributable to the company was $183 million, in comparison with the $172 million in the same quarter last year.
On the Nasdaq, the pre-market shares were down 4.72 percent at $12.88, after closing Tuesday's regular trading 2.50 percent higher.
The loss per share for the fourth quarter was $0.68, same as last year.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Revenue for the fourth quarter rose to $837 million, from $724 million in the same quarter in the prior year.
Looking forward for the fiscal 2027, the co...